Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$3.51 USD
+0.10 (2.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $3.52 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Prime Medicine, Inc. (PRME) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$13.60 | $20.00 | $8.00 | 298.83% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Prime Medicine, Inc. comes to $13.60. The forecasts range from a low of $8.00 to a high of $20.00. The average price target represents an increase of 298.83% from the last closing price of $3.41.
Analyst Price Targets (10)
Broker Rating
Prime Medicine, Inc. currently has an average brokerage recommendation (ABR) of 1.36 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.36 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, nine are Strong Buy, representing 81.82% of all recommendations. A month ago, Strong Buy represented 81.82%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 9 | 9 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.36 | 1.36 | 1.36 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/2/2024 | H.C. Wainwright & Co. | Arthur He | Strong Buy | Strong Buy |
9/30/2024 | Not Identified | Not Identified | Hold | Hold |
8/27/2024 | BMO Capital Markets | Kostas Biliouris | Strong Buy | Strong Buy |
8/8/2024 | Cowen & Co. | Joseph Thome | Strong Buy | Strong Buy |
8/8/2024 | Wedbush Securities | David M Nierengarten | Strong Buy | Strong Buy |
5/16/2024 | Not Identified | Not Identified | Hold | Strong Buy |
5/7/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
4/22/2024 | Chardan Capital Markets | Geulah Livshits | Not Available | Strong Buy |
3/5/2024 | Guggenheim Securities | Debjit Chattopadhyay | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.36 |
ABR (Last week) | 1.36 |
# of Recs in ABR | 11 |
Average Target Price | $13.60 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | -0.44 |
PRME FAQs
Prime Medicine, Inc. (PRME) currently has an average brokerage recommendation (ABR) of 1.36 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms.
The average price target for Prime Medicine, Inc. (PRME) is $13.60. The current on short-term price targets is based on 7 reports.
The forecasts for Prime Medicine, Inc. (PRME) range from a low of $8 to a high of $20. The average price target represents a increase of $287.46 from the last closing price of $3.51.
The current UPSIDE for Prime Medicine, Inc. (PRME) is 287.46%
Based on short-term price targets offered by 10 analysts, the average price target for Prime Medicine, Inc. comes to $13.60. The forecasts range from a low of $8.00 to a high of $20.00. The average price target represents an increase of 298.83% from the last closing price of $3.41.